INTRODUCTION
Burn injury is a common type of traumatic injury. A recent European study estimated the annual incidence of severe burns at between 0.2 and 2.9/10,000 inhabitants 1 
.
Burns cause considerable morbidity and mortality, accounting for over 300,000 deaths per year worldwide 2 , and affect long-term health-related quality of life 3 . Burns are also among the most expensive traumatic injuries, due to the need for long-term hospitalization and rehabilitation periods and costly wound and scar treatment 4, 5 . Different definitions of biomarkers have been proposed. They could be defined as characteristics that can be objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention 4 . In this regard, the WHO proposed a broad definition of biomarker including "almost any measurement reflecting an interaction between a biological system and a potential hazard, which may be chemical, physical, or biological. The measured response may be functional and physiological, biochemical at the cellular level, or a molecular interaction" 5 .Therefore, a biomarker can be considered as everything from the pulse, blood pressure or urine output through basic molecules present in blood and tissues.
The ideal biomarker should be easily and rapidly obtained and must be sensitive, specific and reproducible. Its levels should be modified by therapeutic interventions and it should also be useful for prognostic purposes. Ideally, the processes of procurement and measurement must also be cost-effective. Research into biomarkers has become increasingly important for several reasons. These indicators have helped us to understand the pathophysiology of diseases, allowing early and accurate diagnosis of particular complications and determining the severity of illness. Moreover, they may also be useful for designing new therapeutic targets that can improve outcomes, and for assessing the effectiveness of treatments. Therefore, the aim of this review is to discuss the recent advances in research into the utility of biomarkers in burn injury.
UNDERSTANDING THE PATHOPHYSIOLOGY OF BURN INJURY

The importance of inflammation in burn injury
Understanding the pathophysiology of burn injury is crucial for correct treatment. Burn injuries trigger both local and systemic responses. Indeed, excessive burn load may cause a disproportionate immune response and patients may develop exaggerated systemic inflammatory processes. Thus, the question of how the multiorgan failure occurs in severe burned patient has aroused particular interest. Patients with severe burns are likely to suffer from sepsis that can rapidly develop into a systemic inflammatory response syndrome, which may simultaneously damage many organs such as the lung, the liver, the kidney, the gut or the brain.
In this regard, some studies have investigated the different inflammatory mediators concentration after burn injury. Interleukin (IL)1 receptor antagonist (IL1Ra) has been shown to be increased from the day of admission in patients with second and third degree thermal injuries 6 and its concentrations were significantly higher in nonsurvivors with inhalation injury (Table 1) . IL1Ra has been also correlated with total body surface area (TBSA) during the first week following burn injury 7 . Interestingly, IL1Ra levels were significantly higher in patients with severe sepsis, septic shock and multiorgan dysfunction syndrome (MODS). IL1Ra concentration correlated with other inflammatory mediators, such as IL6, IL8 and tumor necrosis factor (TNF)α, and patient's clinical status regardless the presence of infection. Moreover, IL1Ra levels at admission and its maximum levels were significantly higher in those patients who finally died.
Vindenes et al 8 reported significant correlation between IL1Ra concentration and TBSA and the area of third degree burn, as well as with plasma concentrations of C -reactive protein (CRP). Furthermore, higher concentrations of IL1β and IL1ra were observed in patients who developed infective complications and patients who survived had significantly higher IL1β concentrations. Other studies have also shown that IL6, IL8
and TNFα concentrations are increased in serum after severe injury and they were significantly higher in the septic patients, who all died [9] [10] [11] . Moreover, IL10 concentration has been shown to be higher in nonsurvivors burn patients with proven sepsis 12 . In contrast, a lower second peak of transforming growth factor β1 (TGFβ1) has been observed in septic nonsurvivors burn patients 13 . . Equally, another recent study that included 230 pediatric burns with >30% of TBSA reported higher serum levels of IL6, IL8, G-CSF, MCP1, C-reactive protein in nonsurvivors 18 . All these results suggest that inflammatory reaction plays an important role in burn injury pathophysiology and it may also be important in organ dysfunction generation as well as it may also predict its outcomes.
Significantly, multiorgan dysfunction syndrome (MODS) has been reported as a main cause of death in burn patients 19 ; in fact, in a large cohort of burn patients, MODS was almost invariably present in the patients who died 20 . Consequently, in the overall treatment of burned patients, just as important as the surgical management of the burn are the general supportive measures to minimize the occurrence of organ failure.
Therefore, gaining an understanding of the exact mechanisms involved in burn injury and the genesis of the associated organ dysfunction will help to develop novel therapeutic strategies which can allow successful modulation of the inflammation and improve outcomes. In this regard, despite the inflammatory response, the host's response to burn injury also plays an important role. It has recently been shown that an overwhelming anti-inflammatory response may be associated with worse prognosis. In this sense a cut off of 14pg/ml of IL10 has demonstrated a good discrimination capability between survivors and those burn patients who will not survive 21 . On the other hand, several CD markers of granulocytes, lymphocytes and monocytes have been shown to be overexpressed in survivors 22 .
Fungal wound infection
Historically, infection has been described as one of the main causes of morbidity and mortality in these patients 23 .
In a study that included more than 2500 burn patients, fungal wound infection was independently associated with mortality regardless of age, burn size or the presence of inhalation injury 24 . Although bacterial infections are probably the most common infections in burn patients, severe burn patients also present a higher risk of fungal infection. Some studies have tried to explain this issue.
Inatsu et al 25 , stimulated peripheral blood mononuclear cells (PBMCs) of healthy volunteers and burn patients with Candida albicans antigen (CAg). Burn patient sera were shown to be inhibitory on CAg-stimulated IL-17 production by CD4+ T cells.
However, interleukin (IL) 17 production was induced by burn patient sera when it was previously treated with anti-IL-10 antibody. These results suggest that the high susceptibility to C. albicans infection observed in severe burn patients may be explained by the high levels of IL-10. However, any therapeutic intervention that aims to modulate IL-10 should be performed with caution in order to maintain the balance between inflammatory and anti-inflammatory molecules. Moreover, measuring IL10
and IL17 could be a useful strategy to determine which patients are more at risk of fungal infection.
Inhalation injury
The pathophysiology of inhalation injury has also aroused interest. Recent work has assessed whether the severity of inhalation injury evokes an immune response measurable at a systemic level 26 . The results showed that plasma inflammatory markers were increased with worse inhalation injury severity, and that IL-1Ra had the strongest correlation with injury severity and outcomes. Other issues that have been examined are the factors that modify cell responses to soot, which are probably responsible for the development and severity of acute respiratory distress syndrome and lower respiratory tract infections. In this regard, it has been shown that high levels of IL-10 and IL-12p70 measured early in bronchoalveolar lavage fluid (BALF) of burn patients with inhalation injury may be associated with progression to more severe lung injury 27 . Moreover, these authors proposed a new hypothesis regarding inhalation injury pathophysiology: as Gram-negative pathogen infection was associated with more severe hypoxemia, it is likely that a prolonged increase in IL-10 levels of BAL fluid in these patients would increase immunosuppression and subsequent Gram-negative infection. On the other hand, cigarette smoking, which presents certain similarities to inhalation injury, may primarily trigger IL-33/ST2 production, which then stimulates the synthesis of further key pro-inflammatory cytokines, chemokines and mediators in the airway 28 .
It has also been observed that bronchoalveolar lavage in burn patients with inhalation injury may present different inflammatory patterns according to the severity of the inhalation injury 29 . More importantly, pulmonary hyporesponsiveness has been associated with higher mortality after burn and inhalation injury 30 , suggesting that immunoparalysis is also important in the pathogenesis of inhalation injury and may serve as a potential therapeutic target 31 .
Wound healing
Measuring biomarkers in burns may not only help to understand the pathophysiology of organ dysfunction development and inhalation injury, but may also indicate how the wound healing process occurs. Indeed, burn wound progression remains an important challenge in the overall management of these patients 32 .
Recent experimental results suggested that the delayed wound healing observed in old animals is associated with an increase in keratinocyte 6, matrix metalloproteinase-9 and CD44 33 . Hence, it is likely that the modulation of these biomarkers could improve and accelerate wound healing in elderly patients. Other studies have examined the role of cell death in wound progression. Tan et al. 34 demonstrated that autophagy and apoptosis are important features in wound progression at different time points. As autophagy precedes apoptosis, different treatment strategies should be applied at different time points during the burn injury depending on the primary mechanism involved in wound progression. Autophagic cell death has also been shown to occur early after severe burn 35 and may play an important role in post-burn cardiac dysfunction. Interestingly, pharmacological inhibition of angiotensin II and ROS decreases autophagy and improves cardiac function 
DIAGNOSIS OF COMPLICATIONS AND ASSESSMENT OF THERAPEUTIC
INTERVENTIONS
Fluid resuscitation
Appropriate fluid management is one of the most important issues in the immediate management of burn patients 39 . The aim of this fluid resuscitation is to correct the hypovolemic shock associated with the burn injury. However, avoiding overresuscitation is just as important as correcting the shock. Another study showed that fluid resuscitation of burn patients guided by intrathoracic blood volume index was associated with higher levels of IL6, IL6/IL10 ratio and the IL8/IL10 compared with urine output-guided resuscitation 40 . These results suggest that ITBVI-guided resuscitation may suppress the shift toward anti-inflammatory imbalance. Furthermore, several leukocyte surface markers were significantly higher expressed in the group guided by urine output. These results should make us become aware on the fact that therapeutic interventions may also affect biological processes and may also explain why some treatments succeed or fail in improving outcomes.
Sepsis
Septic complications have been considered an important cause of death in burn patients 41, 42 and, therefore, their early identification may lead to early initiation of treatment and better outcomes. However, diagnosing sepsis in burn patients is still a challenge. In this scenario, several studies have examined the clinical utility of certain biomarkers for diagnosing sepsis and managing critically ill patients. The results of a recent study including more than 400 pediatric burn patients showed that interleukin-8 plasma concentration strongly correlates with the incidence of sepsis 43 . Moreover, patients with higher levels of IL8 had greater burn size, higher incidence of inhalation injury and multiorgan failure, and higher mortality.
On the other hand, a recent meta-analysis on the role of procalcitonin (PCT) in the diagnosis of sepsis and the prognosis of burn patients 44 concluded that adding the determination of PCT to the diagnosis of sepsis may be beneficial. More recently, a large prospective cohort study of 145 burn patients aiming to examine the accuracy of PCT for diagnosing sepsis and localized infections 45 found that maximum PCT plasma level was independently associated with mortality and that patients with septic shock presented higher concentrations of PCT at day 1. More interestingly, PCT levels were higher in patients with sepsis, respiratory tract infection and wound infection than prior to infection. Finally, PCT levels remained higher in septic burn patients with treatment failure, whereas successfully treated patients presented a substantial decrease in PCT concentration between the first and the third day of evolution.
In contrast, a recent study 46 did not find PCT to be a useful marker of sepsis. Indeed, their results showed that N-terminal pro-B-type natriuretic peptide significantly outperformed PCT in the diagnosis of sepsis. Moreover, stroke volume index and systemic vascular resistance index showed an excellent discriminative power for sepsis appearance in critically ill burn patients with TBSA equal to or greater than 15% who were intubated and had no previous cardiovascular comorbidities.
Another point of special interest is the ease of predicting and anticipating the occurrence of infection and sepsis in severe burns. Schultz et al. 47 retrospectively analyzed a cohort of more than 100 burn patients comparing clinical variables that were associated with infection and sepsis. Using a classification and regression tree analysis, the results showed that heart rate ≥110 bpm, systolic blood pressure ≤100 mmHg and intubation were the best predictors of sepsis. In contrast, a fraction of inhaled oxygen >0.25 and maximum temperature ≥39ºC were the best predictors of infection.
Inhalation
In an experimental ovine model of burn injury and smoke inhalation, tocopherol nebulization improved oxygenation, pulmonary shunt fraction, respiratory mechanics, edema formation and bronchiolar obstruction 48 . This study also showed that tocopherol decreased the expression of a nitric oxide synthase inhibitor as well as arginase activity and collagen deposition. This effect helps to improve diffusion capacity and decreases edema formation. The authors conclude that inhalation injury was also mediated by reactive oxygen species and the arginase pathway, and that ROS scavengers such as tocopherol are potentially useful for treating these patients 49 .
More recently, serum concentrations of IL-6, IL-8 and TNF-α have been measured in patients with minor burns and smoke inhalation to assess whether high-frequency percussive ventilation (HFPV) increases inflammatory markers 50 . Interestingly, no increase in serum biomarkers was observed, suggesting that HFPV may not be harmful and could be considered as potential therapeutic tool for these patients.
However, two recent randomized controlled trials of high-frequency oscillatory ventilation (HFOV) in ARDS patients did not find any benefit in mortality 51, 52 .
Abdominal compartment syndrome and renal failure
Burn is an independent risk factor for intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS) and the appearance of these conditions is associated with development of organ failure 53 and higher mortality rates , and is an important cause of increased mortality 55 .
Serum cystatin C and plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) are known to rise 24 to 48 hours before the serum creatinine levels increase.
However, in burns, only NGAL has been proven to be associated with development of early acute kidney injury and mortality 56 .
DESIGNING NEW THERAPEUTIC STRATEGIES AND THE USE OF NEW THERAPEUTIC TARGETS
As oxidative stress and neutrophil activation play important roles in the development and progression of burn injury, they can be considered as good therapeutic targets.
Recently, a small randomized controlled trial analyzed the effect of N-acetylcysteine in 30 burn patients with more than 20% of total body surface area 57 . Although the study lacked sufficient power to draw conclusions regarding clinical outcomes, patients treated with N-acetylcysteine presented lower levels of oxidant stress and plasma cytokines, and the treatment was associated with lower vasopressor requirement.
Recently, Stanojcic et al. 58 investigated the effect of the nucleotide-binding domain, leucine-rich family (NLR), pyrin-containing 3 (NLRP3) inflammasome on insulin resistance and metabolic dysfunction in burn patients. Their results showed that the subcutaneous fat tissue of burn patients presented leucocyte infiltration, which was formed at least in part by monocytes. These monocytes presented increased inflammasome activity that was associated with higher levels of IL-1β. These results provide new evidence regarding the role of the inflammasome in the genesis of stressinduced diabetes and the hypermetabolism related with severe burns, and identify it as a new therapeutic target.
On the other hand, it has been shown that burn injury directly decreases levels of tight junction proteins in the intestinal epithelium, leading to gut injury. This allows the movement of intraluminal contents across the mucosa, which can lead to the development of distant organ injury and multiple organ failure. In fact, the production of gut-derived proinflammatory mediators has been implicated in the shock and multiple organ failure associated with burn injury 59 . Interestingly, in rats with hemorrhagic shock, gut-derived factors that lead to organ injury and increased endothelial permeability were present at higher levels in mesenteric lymph than in the portal vein 60 . Moreover, the results of an experimental study showed that phosphodiesterase inhibition with pentoxifylline may attenuate burn-induced gut injury and, consequently, may protect against the organ failure associated with burn injury 61 . In contrast, ethanol intoxication at the time of burn injury suppresses intestinal immune defenses, impairs gut barrier functions and increases bacterial growth, and thus contributes significantly to the pathogenesis of post-burn distal organ injury 59 . These results suggest that levels of ethanol should be routinely measured in all burn patients at the moment of admission.
In addition, recent experimental data has associated the expression of IL22 and other antimicrobial peptides with an increase in intestinal permeability 62 . Moreover, treatment with IL22 increase the expression of antimicrobial peptides, attenuates the increase in intestinal permeability and reduces bacterial load. These results suggest that IL22
contributes to gut epithelial and immune barrier functions following acute alcohol exposure and burn injury, and that the IL22/antimicrobial peptide pathway may be a useful therapeutic target in order to prevent sepsis and organ dysfunction in patients who present burn injury under alcohol influence.
PROGNOSTIC VALUE
Proteomic techniques facilitate the identification of protein profiles that can serve as More recently, a large study including severely burned children with more than 30% of total body surface affected aimed to determine whether a panel of common biomarkers could be used to predict survival 18 . Non-survivors had significantly higher levels of biomarkers such as IL-6, IL-8, granulocyte colony-stimulating factor, monocyte chemoattractant protein-1, C-reactive protein, glucose, insulin, blood urea nitrogen, creatinine, and bilirubin. Therefore, these biomarkers can be used for monitoring patients and for identifying those at high risk who will benefit from more aggressive treatment. Furthermore, non-survivors are more likely to present sepsis and multiorgan failure, suggesting that these biomarkers could be involved in the pathogenesis of these conditions. Previously, it was shown that the inflammatory and metabolic response is dependent on burn size 64 ; the greater the extent of surface area affected, the higher the inflammation and metabolic response. In addition, patients with a greater percentage of surface burned presented higher indices of sepsis and inhalation injury, higher mechanical ventilation requirement, and increased incidence of myocardial depression and mortality. These authors suggested that patients with a greater extent of body surface burned presented higher levels of proinflammatory cell mediators that trigger and enhance the hypermetabolic response, thus leading to a worse outcome.
Hypoglycemia has also recently been described as a good prognostic marker 65 . One hundred and sixty-six pediatric burn patients who presented one or more episode of hypoglycemia during the first 60 days of admission were matched with patients without hypoglycemia using a propensity score. Matched patients who presented one or more episode of hypoglycemia had greater inflammatory and metabolic response and higher prevalence of sepsis, multiorgan failure and death. Hence, the implementation of therapeutic strategies that minimize the appearance of this complication is imperative.
Hyperlactatemia has been considered as a marker of tissue hypoperfusion. Moreover, the Sepsis Surviving Campaign 66 proposed targeting fluid resuscitation to normalize lactate levels in those patients with initial hyperlactatemia. In burn patients, baseline lactate levels have been reported to predict mortality and their normalization during the first 24 hours of admission is associated with better survival 67 .
More recently, a model combining clinical characteristics and a panel of genomic biomarkers identified burn patients who were at high risk of developing repeated infections 68 . The genomic signature provides new information about susceptibility to infection and, therefore, may lead to the description of new therapeutic targets.
FUTURE DIRECTIONS
Research in biomarkers is continuously evolving. The introduction of techniques such as metabolomics and proteomics may make it possible to detect new biomarkers that are even more sensitive and specific than the ones we have at present. Moreover, the genomic fingerprint may also have an important role to play.
The first aim of research into new biomarkers should be to prevent organ dysfunction, which is one of the key determinants of morbidity and mortality in burn patients. Thus, research in new biomarkers that can predict the appearance of MODS before it occurs is imperative. Second, biomarkers may be useful for stratifying patients according to severity. Correct stratification of patients in terms of severity is the only way to ensure that the right treatment is delivered to the right patient, and will allow us to select high risk patients who are more likely to benefit from more aggressive treatments. Third, it is important to validate new experimental findings clinically, which, in fact, is the key point of translational research. In contrast, experimental research may help to demonstrate the hypothesis generated in clinical studies, as it was the case with the hypothesis that an injurious mechanical ventilation may cause distal organ dysfunction 69 . Thus, experimental research can be helpful in describing the exact mechanisms involved in organ dysfunction generation after burn injury. And finally, the description of new biomarkers will help to develop new therapeutic targets. In this regard, as in the case of the acute respiratory distress syndrome 70 , the use of modified stem cells overexpressing proteins that could enhance wound healing by blocking certain inflammatory pathways may be a point of special interest.
CONCLUSIONS
Several inflammatory mediators have been shown to be increased after burn injury.
They may be important in burn pathophysiology, contributing to organ dysfunction and sepsis apparition, and they may also predict outcomes. Moreover, they have been involved in pathophysiology of some special processes, such as inhalation injury or wound healing. Consequently, some biomarkers have been described as potential therapeutic targets. Importantly, as therapeutic interventions may also affect biological processes, biomarkers may be a useful tool to guide some treatments and may also explain why some treatments succeed or fail in improving outcomes. Therefore, investigation into biomarkers in severe burn patients is a key feature of translational medicine in this area of knowledge. Future research should focus preventing complications of burn injury, stratifying patients according to their risk and severity, designing new therapeutic targets and validating clinically new experimental findings.
